Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids

Article ID	Journal	Published Year	Pages	File Type
8586856	Clinical Nutrition	2018	52 Pages	PDF

Keywords

ALT CPT-1 SREBP ChREBP FAS MRS PNPLA3 ALA RBC NEFA LXR PPAR NAS IκB FXR TLR PKC GCK PUFAs SNPs GGT FATP PFK HNF-4α COX DPA CMKLR1 NAFLD EPA PDH L-PK Red blood cells farnesoid X receptor NFκB AST Aspartate aminotransferase Alanine aminotransferase cyclooxygenase apo apolipoprotein ISI Ethyl esters Non-alcoholic steatohepatitis alpha-linolenic acid Eicosapentaenoic acid docosapentaenoic acid docosahexaenoic acid Polyunsaturated fatty acids Omega-3 fatty acids fatty acid synthase non-esterified fatty acids MRI LOX interleukin non-alcoholic fatty liver disease triacylglycerol TAG یا triacylglycerols Magnetic resonance imaging tumour necrosis factor α Toll-like receptor DHA diacylglycerol DAG Fish oil Metabolic syndrome body mass index BMI Insulin sensitivity index magnetic resonance spectroscopy Nuclear factor κ B Hepatocyte nuclear factor 4 TNF-α Phosphofructokinase lipoxygenase Insulin resistance Algal oil NAFLD activity score Nash sterol regulatory element binding protein carbohydrate response element binding protein Fatty acid transport protein Protein kinase C Single nucleotide polymorphism pyruvate dehydrogenase Carnitine palmitoyltransferase 1 liver X receptor gamma-glutamyl transpeptidase Glucokinase Peroxisome proliferator activated receptor

Related Topics

Health Sciences Medicine and Dentistry Critical Care and Intensive Care Medicine

Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids

Authors

Gabriela S. de Castro, Philip C. Calder,